Ferrer-Gómez Ana, Pian-Arias Héctor, Carretero-Barrio Irene, Navarro-Cantero Antonia, Pestaña David, de Pablo Raúl, Zamorano José Luis, Galán Juan Carlos, Pérez-Mies Belén, Ruz-Caracuel Ignacio, Palacios José
Pathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain.
Front Cardiovasc Med. 2021 Oct 15;8:748396. doi: 10.3389/fcvm.2021.748396. eCollection 2021.
The role of SARS-CoV-2 as a direct cause in the cardiac lesions in patients with severe COVID-19 remains to be established. Our objective is to report the pathological findings in cardiac samples of 30 patients who died after a prolonged hospital stay due to Sars-Cov-2 infection. We performed macroscopic, histological and immunohistochemical analysis of the hearts of 30 patients; and detected Sars-Cov-2 RNA by RT-PCR in the cardiac tissue samples. The median age of our cohort was 69.5 years and 76.6% were male. The median time between symptoms onset and death was 36.5 days. The main comorbidities were arterial hypertension (13 patients, 43.3%), dyslipidemia (11 patients, 36.7%), cardiovascular conditions (8 patients, 26.7%), and obesity (8 patients, 26.7%). Cardiovascular conditions included ischemic cardiopathy in 4 patients (13.3%), hypertrophic cardiomyopathy in 2 patients (6.7%) and valve replacement and chronic heart failure in one patient each (3.3%). At autopsy, the most frequent histopathological findings were coronary artery atherosclerosis (8 patients, 26.7%), left ventricular hypertrophy (4 patients, 13.3%), chronic epicardial inflammation (3 patients, 10%) and adipose metaplasia (2 patients, 6.7%). Two patients showed focal myocarditis, one due to invasive aspergillosis. One additional patient showed senile amyloidosis. Sars-Cov-2 RNA was detected in the heart of only one out of 30 patients, who had the shortest disease evolution of the series (9 days). However, no relevant cardiac histological alterations were identified. In present series, cardiac pathology was only modest in most patients with severe COVID-19. At present, the contribution of a direct effect of SARS-CoV-2 on cardiac lesions remains to be established.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为重症新型冠状病毒肺炎(COVID-19)患者心脏病变的直接病因,其作用仍有待确定。我们的目的是报告30例因Sars-CoV-2感染长期住院后死亡患者心脏样本的病理检查结果。我们对30例患者的心脏进行了大体、组织学和免疫组化分析;并通过逆转录聚合酶链反应(RT-PCR)在心脏组织样本中检测Sars-CoV-2 RNA。我们研究队列的中位年龄为69.5岁,76.6%为男性。症状出现至死亡的中位时间为36.5天。主要合并症为动脉高血压(13例,43.3%)、血脂异常(11例,36.7%)、心血管疾病(8例,26.7%)和肥胖(8例,26.7%)。心血管疾病包括4例(13.3%)缺血性心脏病、2例(6.7%)肥厚型心肌病以及各1例(3.3%)瓣膜置换和慢性心力衰竭。尸检时,最常见的组织病理学发现为冠状动脉粥样硬化(8例,26.7%)、左心室肥厚(4例,13.3%)、慢性心外膜炎症(3例,10%)和脂肪化生(2例,6.7%)。2例显示局灶性心肌炎,1例由侵袭性曲霉病引起。另有1例显示老年性淀粉样变性。30例患者中仅1例心脏检测到Sars-CoV-2 RNA,该例患者病程最短(9天)。然而,未发现相关的心脏组织学改变。在本系列研究中,大多数重症COVID-19患者的心脏病理改变较轻。目前,SARS-CoV-2对心脏病变的直接影响仍有待确定。